Literature DB >> 15621068

Enterostatin and its target mechanisms during regulation of fat intake.

Karin Berger1, Maria Sörhede Winzell, Jie Mei, Charlotte Erlanson-Albertsson.   

Abstract

A high-fat diet easily promotes hyperphagia giving an impression of an uncontrolled process. Fat digestion itself however provides control of fat intake through the digestion itself, carried out by pancreatic lipase and its protein cofactor colipase, and through enterostatin, a peptide released from procolipase during fat digestion. Procolipase (-/-) knockout mice have a severely reduced fat digestion and fat uptake, pointing to a major role of the digestive process itself. With a normal fat digestion, enterostatin basically restricts fat intake by preventing the overconsumption of fat. The mechanism for enterostatin might be an inhibition of a mu-opioid-mediated pathway, demonstrated through binding studies on SK-N-MC-cells and crude brain membranes. Another target protein of enterostatin is the beta-subunit of F1F0-ATPase, displaying a distinct binding of enterostatin, established through an aqueous two-phase partition system. The binding of enterostatin to F1-ATPase was partially displaced by beta-casomorphin, a peptide stimulating fat intake and acting competitively to enterostatin. We frame a hypothesis that regulation of fat intake through enterostatin contains a reward component, which is an F1-ATPase-mediated pathway, possibly complemented with an opioidergic pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15621068     DOI: 10.1016/j.physbeh.2004.08.040

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  12 in total

Review 1.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 2.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 3.  ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Authors:  Zulfiqar Ahmad; Florence Okafor; Sofiya Azim; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

4.  Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut.

Authors:  Natalia Shulzhenko; Andrey Morgun; William Hsiao; Michele Battle; Michael Yao; Oksana Gavrilova; Marlene Orandle; Lloyd Mayer; Andrew J Macpherson; Kathy D McCoy; Claire Fraser-Liggett; Polly Matzinger
Journal:  Nat Med       Date:  2011-11-20       Impact factor: 53.440

5.  A polymorphism in the gene encoding procolipase produces a colipase, Arg92Cys, with decreased function against long-chain triglycerides.

Authors:  Sheryl D'Silva; Xunjun Xiao; Mark E Lowe
Journal:  J Lipid Res       Date:  2007-08-22       Impact factor: 5.922

6.  Enterostatin deficiency increases serum cholesterol but does not influence growth and food intake in mice.

Authors:  Rita Miller; Dymphna D'Agostino; Charlotte Erlanson-Albertsson; Mark E Lowe
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-21       Impact factor: 4.310

Review 7.  Gut fat signaling and appetite control with special emphasis on the effect of thylakoids from spinach on eating behavior.

Authors:  C J Rebello; C E O'Neil; F L Greenway
Journal:  Int J Obes (Lond)       Date:  2015-07-31       Impact factor: 5.095

8.  The effect of vertical sleeve gastrectomy on food choice in rats.

Authors:  H E Wilson-Pérez; A P Chambers; D A Sandoval; M A Stefater; S C Woods; S C Benoit; R J Seeley
Journal:  Int J Obes (Lond)       Date:  2012-02-14       Impact factor: 5.095

Review 9.  ATP synthase: the right size base model for nanomotors in nanomedicine.

Authors:  Zulfiqar Ahmad; James L Cox
Journal:  ScientificWorldJournal       Date:  2014-01-29

10.  Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes.

Authors:  Simon G Anderson; Warwick B Dunn; Moulinath Banerjee; Marie Brown; David I Broadhurst; Royston Goodacre; Garth J S Cooper; Douglas B Kell; J Kennedy Cruickshank
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.